Orphan receptor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 28, 1999
Grant Date -
N/A
app pub date -
May 8, 1997
filing date -
Sep 8, 1995
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to a novel estrogen receptor-related nuclear receptor, hereinafter termed 'ER.beta.' having the amino acid sequence of FIGS. 1, 13A or 14A or substantially the same ambino acid sequence as the amino acid sequence shown in FIGS. 1, 13A or 13B or an amino acid sequence functionally similar to that sequence. The invention also relates to DNA sequences encoding the receptor. The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and other hormonal effects.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully